Tumors from a cohort of 144 glioma subjects were categorized according to the IE1 and SOX2 levels and assigned to four groups: IE1low/SOX2low, IE1low/SOX2high, IE1high/SOX2low, IE1high/SOX2high (S2 Table). Here, SOX2 is linked to central nervous system cancer.